|
Market Closed -
Singapore S.E.
03:20:32 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.0950 SGD | -.--% |
|
-.--% | -75.00% |
| Market Cap | 15.82M 3.03M 2.37M 2.12M 1.96M 1.77M 3.32M 225M 3.37M 23.54M 9.32M 118M 8.9M 8.71M 372M | P/E 2024 |
11.1x | P/E 2025 | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 27.2M 5.21M 4.08M 3.64M 3.36M 3.05M 5.7M 387M 5.8M 40.48M 16.03M 203M 15.3M 14.98M 639M | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 1.76x |
| Free-Float |
21.36% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | -24.00% | ||
| 3 months | -30.66% | ||
| 6 months | -73.24% | ||
| Current year | -75.00% |
| 1 month | 0.1 |  | 0.1 |
| Current year | 0.08 | | 0.42 |
| 1 year | 0.08 | | 0.42 |
| 3 years | 0.06 | | 0.7 |
| 5 years | 0.06 | | 0.7 |
| 10 years | 0.06 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | 63 | 2017-12-30 |
Pei Chan Tang
SEC | Corporate Secretary | - | - |
Moi Heyang Lin
SEC | Corporate Secretary | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Heng Ching Chew
CHM | Chairman | 75 | 2009-01-04 |
Xue Dan Wu
BRD | Director/Board Member | 63 | 2004-04-15 |
Yong Teng Seow
BRD | Director/Board Member | 51 | 2023-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -77.11% | +10.47% | 2.36M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.98% | +1.95% | +25.61% | +63.29% | 400.37B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 67.65M 12.96M 10.14M 9.06M 8.37M 7.58M 14.19M 963M 14.42M 101M 39.86M 504M 38.06M 37.25M 1.59B | 43.75M 8.38M 6.56M 5.86M 5.41M 4.9M 9.17M 623M 9.33M 65.12M 25.78M 326M 24.62M 24.09M 1.03B |
| Net income | 8.28M 1.59M 1.24M 1.11M 1.02M 928K 1.74M 118M 1.76M 12.32M 4.88M 61.73M 4.66M 4.56M 195M | -4.3M -824K -645K -576K -532K -482K -902K -61.21M -917K -6.4M -2.53M -32.07M -2.42M -2.37M -101M |
| Net Debt | 11.66M 2.23M 1.75M 1.56M 1.44M 1.31M 2.44M 166M 2.49M 17.35M 6.87M 86.94M 6.56M 6.42M 274M | 11.38M 2.18M 1.71M 1.52M 1.41M 1.28M 2.39M 162M 2.43M 16.94M 6.71M 84.88M 6.4M 6.27M 268M |
Employees
1,096
Sector
Pharmaceuticals
- Stock Market
- Stocks
- BFK Stock
Select your edition
All financial news and data tailored to specific country editions
